Clinical Trials & Results
Search or filter the listing below to find a trial or results of a completed trial.
Showing 20 of 247 Results
All Results
No Results
No results found
Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.
A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma (CONNECT1)
- Condition(s):
- Asthma
- Status:
- Completed
- Requirements:
- 13 Years and older
- Interventions:
- Drug: Albuterol eMDPI DS | Drug: albuterol
A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma (CONNECT2)
- Condition(s):
- Asthma
- Status:
- Completed
- Requirements:
- 13 Years and older
- Interventions:
- Drug: Fluticasone propionate/salmeterol (FS) | Drug: Albuterol | Drug: Standard of Care Asthma Medication | Drug: Standard of Care Rescue Medication
A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With Migraine
- Condition(s):
- Migraine Headache
- Status:
- Completed
- Requirements:
- 18 Years to 70 Years
- Interventions:
- Drug: Fremanezumab | Drug: Placebo
A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With Schizophrenia (SOLARIS)
- Condition(s):
- Schizophrenia
- Status:
- Completed
- Requirements:
- 18 Years to 64 Years
- Interventions:
- Drug: TV-44749 | Drug: Placebo
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- Condition(s):
- Asthma
- Status:
- Completed
- Requirements:
- 12 Years and older
- Interventions:
- Drug: Fp/ABS, FP, ABS, Placebo
A Study to Assess New Formulations of TEV-56286
- Condition(s):
- Healthy Participants
- Status:
- Completed
- Requirements:
- 18 years to 60 Years
- Interventions:
- Drug: TEV-56286 Test | Drug: TEV-56286 Reference
A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod
- Condition(s):
- Relapsing Remitting Multiple Sclerosis
- Status:
- Completed
- Requirements:
- 18 Years to 50 Years
- Interventions:
- Drug: laquinimod 0.3 | Drug: laquinimod 0.6 | Other: Placebo
A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive Disorder
- Condition(s):
- Migraine | Major Depressive Disorder
- Status:
- Completed
- Requirements:
- 18 Years to 70 Years
- Interventions:
- Drug: Fremanezumab | Drug: Placebo
A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
- Condition(s):
- Crohn Disease|Colitis, Ulcerative
- Status:
- Active, not recruiting
- Requirements:
- 18 Years to 75 Years
- Interventions:
- Drug: TEV-48574
A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive Age
- Condition(s):
- Contraception
- Status:
- Completed
- Requirements:
- 18 Years to 45 Years
- Interventions:
- Drug: TV-46046|Drug: Depo-subQ Provera
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
- Condition(s):
- Asthma
- Status:
- Active, not recruiting
- Requirements:
- 4 years and older
- Interventions:
- Drug: TEV-56248 | Drug: Albuterol sulfate
A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age
- Condition(s):
- Migraine
- Status:
- Completed
- Requirements:
- 6 Years to 17 Years
- Interventions:
- Drug: Fremanezumab | Drug: Placebo
A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age
- Condition(s):
- Migraine
- Status:
- Completed
- Requirements:
- 6 Years to 17 Years
- Interventions:
- Drug: Fremanezumab | Drug: Placebo
A Study to Test if TEV-48574 is Effective in Relieving Asthma
- Condition(s):
- Asthma
- Status:
- Terminated
- Requirements:
- 18 Years and older
- Interventions:
- Drug: TEV-48574 | Drug: Placebo
A Study to Test if TEV-50717 is Safe and Effective in Relieving Abnormal Involuntary Movements in Cerebral Palsy
- Condition(s):
- Cerebral Palsy, Dyskinetic
- Status:
- Terminated
- Requirements:
- 6 Years to 18 Years
- Interventions:
- Drug: TEV-50717
A Study to Test if TEV-53275 is Effective in Relieving Asthma
- Condition(s):
- Asthma
- Status:
- Terminated
- Requirements:
- 18 Years and Older
- Interventions:
- Drug: TEV-53275 Dose A | Drug: TEV-53275 Dose B | Drug: Placebo
A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia (SHINE)
- Condition(s):
- Schizophrenia
- Status:
- Completed
- Requirements:
- 13 Years to 65 Years
- Interventions:
- Drug: TV-46000 | Drug: Placebo
A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease (RELIEVE UCCD)
- Condition(s):
- Crohn Disease|Colitis, Ulcerative
- Status:
- Completed
- Requirements:
- 18 Years to 75 Years
- Interventions:
- Drug: TEV-48574 | Drug: Placebo
A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With Fibromyalgia
- Condition(s):
- Fibromyalgia
- Status:
- Terminated
- Requirements:
- 18 Years to 75 Years
- Interventions:
- Drug: Fremanezumab|Drug: Placebo
A Trial to Assess TEV-56286 at Different Doses in Healthy Participants
- Condition(s):
- Healthy Volunteers
- Status:
- Recruiting
- Requirements:
- 18 years to 60 years
- Interventions:
- TEV-56286